St. Jude Medical (St. Paul, Minnesota) in early July reported U.S. and European regulatory approvals to expand the capabilities of its Frontier II cardiac resynchronization therapy pacemaker (CRT-P) to include QuickOpt Timing Cycle Optimization, giving physicians a new option to manage therapy for patients based on their individual needs.